SynthesisWorld journal of surgical oncology2024

Identifying subgroups deriving the most benefit from PD-1 checkpoint inhibition plus chemotherapy in advanced metastatic triple-negative breast cancer: a systematic review and meta-analysis.

Shengfa Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.